Skip to main content

Advertisement

Table 3 Different therapeutic options used in our cohort

From: Membranous nephropathy: a retrospective observational study of membranous nephropathy in north east and central London

Treatment N (%)
Conservative 48 (32)
Cyclophosphamide 36 (24)
Calcineurin inhibitors 38 (26)
Antiproliferative agents (MMF/azathioprine) 21 (14)
Rituximab/steroid monotherapy/other 1/3/1 (Total 3%)